Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Identification of high-risk subjects in nonalcoholic fatty liver disease

Christiane Stern, Laurent Castera

Clin Mol Hepatol. 2023;29(Suppl):S196-S206. Published online December 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0431

View: 5275 Download: 270 Web of Science: 8 Crossref: 8

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne

Clin Mol Hepatol. 2023;29(Suppl):S157-S170. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0348

View: 3604 Download: 298 Web of Science: 12 Crossref: 13

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future

Jung Hwan Yu, Han Ah Lee, Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S136-S149. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0436

View: 3711 Download: 213 Web of Science: 13 Crossref: 12

Original Article

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions

Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

Clin Mol Hepatol. 2023;29(2):465-481. Published online February 20, 2023

DOI: https://doi.org/10.3350/cmh.2022.0327

View: 4601 Download: 222 Web of Science: 3 Crossref: 6

Editorial

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease

Maamon Basheer, Mohamed Naffaa, Nimer Assy

Clin Mol Hepatol. 2023;29(2):398-400. Published online February 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0045

View: 2718 Download: 122

Review

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin

Clin Mol Hepatol. 2023;29(1):77-98. Published online October 13, 2022

DOI: https://doi.org/10.3350/cmh.2022.0237

View: 8605 Download: 614 Web of Science: 26 Crossref: 33

Letter to the Editor

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0040

View: 4699 Download: 316 Web of Science: 6 Crossref: 5

Editorial

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2021;27(2):273-277. Published online February 1, 2021

DOI: https://doi.org/10.3350/cmh.2021.0019

View: 4261 Download: 131 Web of Science: 5 Crossref: 6

Original Article

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection

Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim

Clin Mol Hepatol. 2020;26(1):33-44. Published online June 27, 2019

DOI: https://doi.org/10.3350/cmh.2018.0073

View: 5830 Download: 183 Web of Science: 18 Crossref: 15

Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases

San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón

Clin Mol Hepatol. 2018;24(4):384-391. Published online July 4, 2018

DOI: https://doi.org/10.3350/cmh.2018.0004

View: 7727 Download: 196 Web of Science: 11 Crossref: 10

Editorial

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level

Mi Young Jeon, Beom Kyung Kim, Seung Up Kim

Clin Mol Hepatol. 2018;24(4):367-369. Published online September 19, 2018

DOI: https://doi.org/10.3350/cmh.2018.1008

View: 6545 Download: 167 Web of Science: 4 Crossref: 4

Review

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 12905 Download: 509 Web of Science: 37 Crossref: 39

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 15387 Download: 537 Web of Science: 84 Crossref: 81

Liver Imaging

What we need to know when performing and interpreting US elastography

So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee

Clin Mol Hepatol. 2016;22(3):406-414. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0106

View: 12452 Download: 280 Web of Science: 38 Crossref: 40

Original Article

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis

Jong Ho Chung, Hyung Su Ahn, Sang Gyune Kim, Yun Nah Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(2):156-164. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.156

View: 9990 Download: 123 Crossref: 30

3

Comparison of various noninvasive serum markers of Liver fibrosis in chronic viral Liver disease

Sun Min Kim , Joo Hyun Sohn , Tae Yeob Kim , Young Wook Roh , Chang Soo Eun , Yong Cheol Jeon , Dong Soo Han , Young Ha Oh

Clin Mol Hepatol. 2009;15(4):454-463. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.454

View: 5911 Download: 77 Crossref: 14

An Experimental Model of Hepatic Fibrosis Induced by Alcohol and CCl₄ : Can the Lipopolysaccharide Prevent Liver Injury Induced by Alcohol and CCl₄ ?

Hee Bok Chae, M.D., Lee Chan Jang, M.D.*, Seon Mee Park, M.D., Bo Ra Son, M.D.†, Rohyun Sung, M.D.‡, Jae Woon Choi, M.D.*

Clin Mol Hepatol. 2002;8(2):173-178. Published online January 1, 2000

View: 2379 Download: 31

The Relevance of Degree of Liver Fibrosis, Ito cell, and PKC Activity in Hepatic Fibrogenesis

Young Mi Jung, M.S., Kee Tack Jang, M.D., Yun Sil Lee Ph.D., In Kyoung Lim M.D., Mi Ran Kim, M.S., Min Jae Lee, Ph.D., Eui Keun Ham, M.D., Je G Chi, M.D., Jeong Wook Seo, M.D., In Ae Park, M.D., Chong Jai Kim, M.D., and Ja-June Jang, M.D.

Clin Mol Hepatol. 1998;4(4):381-392. Published online January 1, 2000

View: 2248 Download: 16

Review

Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis

Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li

Received January 11, 2024 Accepted February 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0022 [Epub ahead of print]

View: 675 Download: 100

1 |

Viewed By 5423	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5391	MAFLD: How is it different from NAFLD?
Viewed By 5280	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3945	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3936	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search